---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-231963"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:32:36.218200+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Gillian Cannon resigns from Corcept board; consulting agreement signed

## Summary
- Dr. Gillian Cannon resigned from the Board effective October 10, 2025, with no disagreement over operations or policies.
- Company and Cannon entered consulting agreement from effective date until 2026 annual stockholder meeting.
- Consulting fee: $5,708.33 per month; previously awarded stock options continue vesting per original schedule.

## SEC filing metadata
- accession: 0001193125-25-231963
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/0001193125-25-231963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/d817312d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-231963
- JSON: https://secwatch.observer/filing/0001193125-25-231963.json
- Plain text: https://secwatch.observer/filing/0001193125-25-231963.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.